AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 23625331 — intervention group
Group type: EXPERIMENTAL
Intervention: Evening primrose oil (500 mg, 2 capsules per day for 6 weeks)
Number of subjects: 56
Study 23625331 — intervention group
Group type: COMPARATOR
Intervention: Placebo (2 capsules per day for 6 weeks)
Number of subjects: 56
Study 22212765 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (n=33) received weekly topic-based reading instructions and five telephone consultations with an audiologist.
Number of subjects: 69
Study 22212765 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=36) read the same book but did not have discussions with a professional.
Number of subjects: 69
Study 22212765 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (n=33)
Number of subjects: 69
Study 22212765 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=36)
Number of subjects: 69
Study 19501610 — intervention group
Group type: EXPERIMENTAL
Intervention: Horizontal grating patterns as targets with vertical suppressor bars
Number of subjects: 0
Study 19501610 — intervention group
Group type: EXPERIMENTAL
Intervention: Inclusion of a spatial gap between vertical suppressors and the target
Number of subjects: 0
Study 19501610 — intervention group
Group type: EXPERIMENTAL
Intervention: Luminance variation along the target
Number of subjects: 0
Study 16418085 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid-sequence intubation (RSI) with etomidate (0.3 mg/kg) and succinylcholine (1.5 mg/kg)
Number of subjects: 49
Study 16418085 — intervention group
Group type: COMPARATOR
Intervention: Etomidate-only intubation (EOI) with etomidate (0.3 mg/kg)
Number of subjects: 49
Study 12690269 — intervention group
Group type: EXPERIMENTAL
Intervention: Early insertion of tympanostomy tubes
Number of subjects: 429
Study 12690269 — intervention group
Group type: COMPARATOR
Intervention: Delayed insertion of tympanostomy tubes (up to 9 months later)
Number of subjects: 429
Study 12690269 — intervention group
Group type: EXPERIMENTAL
Intervention: Subgroup analysis of children with bilateral, continuous MEE
Number of subjects: 429
Study 12690269 — intervention group
Group type: EXPERIMENTAL
Intervention: Subgroup analysis of children with the greatest degrees of hearing loss
Number of subjects: 429
Study 11090788 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine 5 mg/benazepril 10 mg
Number of subjects: 1079
Study 11090788 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine 5 mg/benazepril 20 mg
Number of subjects: 1079
Study 11090788 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine 30 mg
Number of subjects: 1079
Study 11090788 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine 60 mg
Number of subjects: 1079
Study 11090788 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine 5 mg
Number of subjects: 1079
Study 11090788 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine 10 mg
Number of subjects: 1079
Study 11090788 — intervention group
Group type: COMPARATOR
Intervention: Low-dose calcium antagonists
Number of subjects: 1079
Study 8815943 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary angiography
Number of subjects: 21772
Study 8815943 — intervention group
Group type: EXPERIMENTAL
Intervention: Revascularization
Number of subjects: 21772
Study 8815943 — intervention group
Group type: EXPERIMENTAL
Intervention: Age < 73 years
Number of subjects: 21772
Study 8815943 — intervention group
Group type: EXPERIMENTAL
Intervention: Age ≥ 73 years
Number of subjects: 21772
Study 8815943 — intervention group
Group type: EXPERIMENTAL
Intervention: Availability of angioplasty
Number of subjects: 21772
Study 8815943 — intervention group
Group type: EXPERIMENTAL
Intervention: Recurrent ischemia
Number of subjects: 21772
Study 8815943 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary anatomy
Number of subjects: 21772
Study 1592777 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 14
Study 1592777 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 3985104 — intervention group
Group type: EXPERIMENTAL
Intervention: New styrene-type gas-permeable hard (GPH) lens
Number of subjects: 10
Study 3985104 — intervention group
Group type: COMPARATOR
Intervention: Other GPH lenses and some soft lenses
Number of subjects: 10
Study 29724196 — intervention group
Group type: EXPERIMENTAL
Intervention: Keeping Safe programme (intervention group)
Number of subjects: 80
Study 29724196 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group (control group)
Number of subjects: 80
Study 26898481 — intervention group
Group type: EXPERIMENTAL
Intervention: Entecavir (ETV)
Number of subjects: 175
Study 26898481 — intervention group
Group type: EXPERIMENTAL
Intervention: Peginterferon (PEG‐IFN) add-on
Number of subjects: 175
Study 26898481 — intervention group
Group type: EXPERIMENTAL
Intervention: HBcrAg
Number of subjects: 175
Study 24353344 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidant supplementation (vitamin E, 400 IU; vitamin C, 500 mg; selenium, 50 μg)
Number of subjects: 44
Study 24353344 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 23213946 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamins A, C, and E intake (both natural and supplementary)
Number of subjects: 180
Study 23213946 — intervention group
Group type: COMPARATOR
Intervention: Healthy examinees (control group)
Number of subjects: 180
Study 20491360 — intervention group
Group type: EXPERIMENTAL
Intervention: Telmisartan 80 mg daily
Number of subjects: 5926
Study 20491360 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5926
Study 17980503 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation
Number of subjects: 100
Study 17980503 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 100
Study 17980503 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation in patients with Stages III-IV disease
Number of subjects: 100
Study 16208784 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 ml bupivacaine 0.25% into the margin
Number of subjects: 27
Study 16208784 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 ml bupivacaine 0.25% into the cavity
Number of subjects: 27
Study 16208784 — intervention group
Group type: COMPARATOR
Intervention: 5 ml physiological saline into the cavity
Number of subjects: 27
Study 11835037 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril 6.25 mg
Number of subjects: 205
Study 11835037 — intervention group
Group type: EXPERIMENTAL
Intervention: Trandolapril 0.5 mg
Number of subjects: 205
Study 11835037 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 205
Study 12523874 — intervention group
Group type: EXPERIMENTAL
Intervention: Atomoxetine
Number of subjects: 291
Study 12523874 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 291
Study 9548163 — intervention group
Group type: EXPERIMENTAL
Intervention: Implanon
Number of subjects: 32
Study 9548163 — intervention group
Group type: COMPARATOR
Intervention: Norplant
Number of subjects: 32
Study 8040991 — intervention group
Group type: EXPERIMENTAL
Intervention: Repair of incisional hernia using synthetic mesh
Number of subjects: 55
Study 8040991 — intervention group
Group type: COMPARATOR
Intervention: Simple repair of incisional hernia
Number of subjects: 55
Study 2837105 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol (0.42 g/kg) + marihuana (2.4% THC)
Number of subjects: 6
Study 2837105 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol (0.85 g/kg) + marihuana (2.4% THC)
Number of subjects: 6
Study 2837105 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo ethanol + marihuana (2.4% THC)
Number of subjects: 6
Study 2837105 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose ethanol (0.42 g/kg) + placebo marihuana
Number of subjects: 6
Study 2837105 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose ethanol (0.85 g/kg) + placebo marihuana
Number of subjects: 6
Study 2837105 — intervention group
Group type: COMPARATOR
Intervention: Placebo ethanol + placebo marihuana
Number of subjects: 6
Study 2837105 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose ethanol (0.42 g/kg) + marihuana (2.4% THC)
Number of subjects: 6
Study 2837105 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose ethanol (0.85 g/kg) + marihuana (2.4% THC)
Number of subjects: 6
Study 2837105 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol (0.42 g/kg) + marihuana (0.0004% THC)
Number of subjects: 6
Study 2837105 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol (0.85 g/kg) + marihuana (0.0004% THC)
Number of subjects: 6
Study 2837105 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo ethanol + marihuana (0.0004% THC)
Number of subjects: 6
Study 31421990 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS (2 mA) paired with active MBM (20 min)
Number of subjects: 30
Study 31421990 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS paired with sham MBM
Number of subjects: 30
Study 29173603 — intervention group
Group type: EXPERIMENTAL
Intervention: Omron HEM 907 in closed areas
Number of subjects: 258
Study 29173603 — intervention group
Group type: EXPERIMENTAL
Intervention: Omron HEM 907 in open areas
Number of subjects: 258
Study 29173603 — intervention group
Group type: COMPARATOR
Intervention: BpTRU
Number of subjects: 258
Study 26562605 — intervention group
Group type: EXPERIMENTAL
Intervention: General anxiety sensitivity (AS) factor
Number of subjects: 329
Study 26562605 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive, physical, and social concerns subfactors of AS
Number of subjects: 329
Study 24021419 — intervention group
Group type: EXPERIMENTAL
Intervention: Teen CHAT online educational intervention
Number of subjects: 46
Study 24021419 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 46
Study 21680702 — intervention group
Group type: EXPERIMENTAL
Intervention: SRT501 (micronized resveratrol) 5.0 g daily for 14 days
Number of subjects: 0
Study 21680702 — intervention group
Group type: EXPERIMENTAL
Intervention: SRT501 (micronized resveratrol)
Number of subjects: 0
Study 18459077 — intervention group
Group type: EXPERIMENTAL
Intervention: Transoral Gastroplasty (TOGA) system
Number of subjects: 11
Study 16796856 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac sympathetic blockade (TEB)
Number of subjects: 39
Study 16796856 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 39
Study 14555261 — intervention group
Group type: EXPERIMENTAL
Intervention: Clodronate (100 mg im/week) plus calcium (1000 mg) and vitamin D (800 UI)
Number of subjects: 163
Study 14555261 — intervention group
Group type: COMPARATOR
Intervention: Calcium (1000 mg) and vitamin D (800 UI) alone
Number of subjects: 163
Study 11087879 — intervention group
Group type: EXPERIMENTAL
Intervention: Hip protector
Number of subjects: 1801
Study 11087879 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1801
Study 11087879 — intervention group
Group type: EXPERIMENTAL
Intervention: Hip protector (while wearing)
Number of subjects: 1801
Study 11087879 — intervention group
Group type: EXPERIMENTAL
Intervention: Hip protector (while not wearing)
Number of subjects: 1801
Study 8741720 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive therapy targeted specifically on the single symptom of their delusional belief(s)
Number of subjects: 6
Study 1565419 — intervention group
Group type: EXPERIMENTAL
Intervention: Rigid gas-permeable contact lens extended wear (EWRGP)
Number of subjects: 88
Study 1565419 — intervention group
Group type: EXPERIMENTAL
Intervention: Soft lens extended wear (SLEW)
Number of subjects: 88
Study 1565419 — intervention group
Group type: COMPARATOR
Intervention: RGP daily wear (DWRGP)
Number of subjects: 88
Study 31685212 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcabene 300 mg for 4 weeks
Number of subjects: 8
Study 31685212 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcabene 600 mg for 4 weeks
Number of subjects: 8
Study 31685212 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcabene 900 mg for 4 weeks
Number of subjects: 8
Study 29767677 — intervention group
Group type: EXPERIMENTAL
Intervention: docetaxel + bavituximab 3 mg/kg
Number of subjects: 597
Study 29767677 — intervention group
Group type: COMPARATOR
Intervention: docetaxel + placebo
Number of subjects: 597
Study 27450686 — intervention group
Group type: EXPERIMENTAL
Intervention: guided iCBT‐I
Number of subjects: 128
Study 27450686 — intervention group
Group type: COMPARATOR
Intervention: treatment as usual
Number of subjects: 128
Study 23625982 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg prednisolone
Number of subjects: 39
Study 23625982 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg prednisolone
Number of subjects: 39
Study 23625982 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 23044285 — intervention group
Group type: EXPERIMENTAL
Intervention: Aripiprazole (10 or 30 mg/day)
Number of subjects: 0
Study 23044285 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 19996767 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (RIPC)
Number of subjects: 40
Study 19996767 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study 17636226 — intervention group
Group type: EXPERIMENTAL
Intervention: Tibolone
Number of subjects: 102
Study 17636226 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 102
Study 16195034 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate intermittent physical exercise (exercised group)
Number of subjects: 57
Study 16195034 — intervention group
Group type: COMPARATOR
Intervention: Light work in the barracks (non-exercised control group)
Number of subjects: 57
Study 12012138 — intervention group
Group type: EXPERIMENTAL
Intervention: diclofenac-colestyramine
Number of subjects: 32
Study 12012138 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 32
Study 10393997 — intervention group
Group type: EXPERIMENTAL
Intervention: Pacifier with sucrose
Number of subjects: 25
Study 10393997 — intervention group
Group type: EXPERIMENTAL
Intervention: Pacifier with water
Number of subjects: 25
Study 10393997 — intervention group
Group type: EXPERIMENTAL
Intervention: Prone position
Number of subjects: 25
Study 10393997 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 25
Study 7557813 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline 30 mg/d
Number of subjects: 30
Study 7557813 — intervention group
Group type: EXPERIMENTAL
Intervention: Flupentixol 1.5 mg/d
Number of subjects: 30
Study 7557813 — intervention group
Group type: EXPERIMENTAL
Intervention: Clotiazepam 15 mg/d
Number of subjects: 30
Study 7557813 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 7557813 — intervention group
Group type: EXPERIMENTAL
Intervention: All drugs compared
Number of subjects: 30
Study 7557813 — intervention group
Group type: EXPERIMENTAL
Intervention: Meta-analysis of chronic GAD
Number of subjects: 30
Study 2149728 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline + lithium
Number of subjects: 40
Study 2149728 — intervention group
Group type: COMPARATOR
Intervention: Amitriptyline alone
Number of subjects: 40
Study 2149728 — intervention group
Group type: COMPARATOR
Intervention: Lithium alone
Number of subjects: 40
Study 7235102 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (personal contact added to standard treatment)
Number of subjects: 124
Study 7235102 — intervention group
Group type: COMPARATOR
Intervention: Control group (notification to parents by a form letter)
Number of subjects: 124
Study 31445061 — intervention group
Group type: EXPERIMENTAL
Intervention: anodal tDCS + exercise
Number of subjects: 15
Study 31445061 — intervention group
Group type: EXPERIMENTAL
Intervention: sham stimulation + exercise
Number of subjects: 15
Study 27887820 — intervention group
Group type: EXPERIMENTAL
Intervention: TVD group (with real-time tidal volume feedback)
Number of subjects: 14
Study 27887820 — intervention group
Group type: COMPARATOR
Intervention: Control group (without tidal volume feedback)
Number of subjects: 14
Study 26994359 — intervention group
Group type: EXPERIMENTAL
Intervention: Oil in Baby SkincaRE (OBSeRvE) intervention
Number of subjects: 115
Study 26994359 — intervention group
Group type: COMPARATOR
Intervention: No oil control group
Number of subjects: 115
Study 24908596 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% miconazole
Number of subjects: 50
Study 24908596 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% Uncaria tomentosa gel
Number of subjects: 50
Study 24908596 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 22011667 — intervention group
Group type: EXPERIMENTAL
Intervention: Palifermin
Number of subjects: 95
Study 19755647 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin treatment
Number of subjects: 979
Study 19755647 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 979
Study 17186282 — intervention group
Group type: EXPERIMENTAL
Intervention: Graded Activity (GA) intervention
Number of subjects: 134
Study 17186282 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 134
Study 15319379 — intervention group
Group type: EXPERIMENTAL
Intervention: NuvaRing
Number of subjects: 40
Study 15319379 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined oral contraceptive (COC)
Number of subjects: 40
Study 11451620 — intervention group
Group type: EXPERIMENTAL
Intervention: Oestrogen only (Estraderm TTS 50) (n=6)
Number of subjects: 24
Study 11451620 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal oestrogen and progesterone (Estraderm TTS 50 and 0.4 mg progesterone vaginal suppository) (n=7)
Number of subjects: 24
Study 11451620 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral oestrogen and progesterone (2 mg Progynova and 0.4 mg progesterone vaginal suppository) (n=8)
Number of subjects: 24
Study 11451620 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=3)
Number of subjects: 24
Study 9509747 — intervention group
Group type: EXPERIMENTAL
Intervention: Pupil noise amplitude measurement in narcoleptics
Number of subjects: 20
Study 9509747 — intervention group
Group type: COMPARATOR
Intervention: Pupil noise amplitude measurement in controls
Number of subjects: 20
Study 9509747 — intervention group
Group type: EXPERIMENTAL
Intervention: Statistical classification of subjects
Number of subjects: 20
Study 9509747 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypothesis testing for class membership
Number of subjects: 20
Study 8066557 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled acetaldehyde (0.8 mg/ml for 4 minutes)
Number of subjects: 9
Study 8066557 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled acetaldehyde with terfenadine
Number of subjects: 9
Study 8066557 — intervention group
Group type: COMPARATOR
Intervention: Oral placebo and inhaled saline
Number of subjects: 9
Study 2848786 — intervention group
Group type: EXPERIMENTAL
Intervention: levamisole (2.5 mg/kg twice weekly for 2 years or until tumor progression)
Number of subjects: 285
Study 2848786 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 285
Study 31802541 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine effect-site concentration (Ce)
Number of subjects: 45
Study 31144584 — intervention group
Group type: EXPERIMENTAL
Intervention: Selection strategy
Number of subjects: 0
Study 31144584 — intervention group
Group type: EXPERIMENTAL
Intervention: Rejection strategy
Number of subjects: 0
Study 28539066 — intervention group
Group type: EXPERIMENTAL
Intervention: Water-based treatment
Number of subjects: 36
Study 28539066 — intervention group
Group type: COMPARATOR
Intervention: Land-based treatment
Number of subjects: 36
Study 26062180 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture applied to bilateral Fushe (SP 13) and Shuidao (ST 28); 2 Hz/50 Hz, retaining for 30 min, one treatment
Number of subjects: 154
Study 26062180 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture
Number of subjects: 154
Study 26062180 — intervention group
Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 154
Study 24183981 — intervention group
Group type: EXPERIMENTAL
Intervention: delNS1‐trivalent vaccine at 7.0log10 TCID50/subject
Number of subjects: 80
Study 24183981 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 22048110 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoster vaccine (ZV)
Number of subjects: 11980
Study 22048110 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11980
Study 19185236 — intervention group
Group type: EXPERIMENTAL
Intervention: Coaxial clear corneal microincision cataract surgery (MICS)
Number of subjects: 60
Study 19185236 — intervention group
Group type: COMPARATOR
Intervention: Coaxial small‐incision cataract surgery (SICS)
Number of subjects: 60
Study 18167249 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy combined with intraoperative endoscopic sphincterotomy (LC-IOEST)
Number of subjects: 275
Study 18167249 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic cholecystectomy combined with laparoscopic common bile duct exploration (LC-LCBDE)
Number of subjects: 275
Study 16353407 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body MRI
Number of subjects: 21
Study 12379622 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-TNF monoclonal antibody infliximab
Number of subjects: 80
Study 12379622 — intervention group
Group type: COMPARATOR
Intervention: Etanercept
Number of subjects: 80
Study 9579768 — intervention group
Group type: EXPERIMENTAL
Intervention: Quinapril (ACE inhibitor)
Number of subjects: 0
Study 7543956 — intervention group
Group type: EXPERIMENTAL
Intervention: rG.CSF (5 micrograms/kg/d d.i.v.)
Number of subjects: 124
Study 7543956 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 124
Study 2651489 — intervention group
Group type: EXPERIMENTAL
Intervention: Alprazolam, 0.5-6.0 mg/day
Number of subjects: 14
Study 2651489 — intervention group
Group type: EXPERIMENTAL
Intervention: Adinazolam mesylate, 10-120 mg/day
Number of subjects: 14
Study 2651489 — intervention group
Group type: COMPARATOR
Intervention: Placebo (baseline condition)
Number of subjects: 14
Study 21116 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluphenazine/nortriptyline (specific antidepressant together with an anxiolytic)
Number of subjects: 0
Study 21116 — intervention group
Group type: COMPARATOR
Intervention: Potassium clorazepate (pure anxiolytic)
Number of subjects: 0